KEGG DRUG

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	Risankizumab	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	4件: 37, 96, 97, 271
2	Risankizumab (Genetical Recombination)	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 97
3	Risankizumab 10 mg/ml	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 96
4	Risankizumab 180 mg SC	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 96
5	Risankizumab 600 mg IV	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 96
6	Risankizumab 90 mg/ml	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 96
7	Risankizumab IV	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 96, 97
8	Risankizumab On-Body Injector (OBI)	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	1件: 96
9	Risankizumab SC	1件: Risankizumab	1件: D11052 (Name: Risankizumab)	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	2件: 96, 97